224 related articles for article (PubMed ID: 36277957)
1. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
2. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
[TBL] [Abstract][Full Text] [Related]
3. A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis.
Vuppalanchi R; Are V; Telford A; Young L; Mouchti S; Ferreira C; Kettler C; Gromski M; Akisik F; Chalasani N
JHEP Rep; 2023 Oct; 5(10):100834. PubMed ID: 37663118
[TBL] [Abstract][Full Text] [Related]
4. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
5. Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
Gilligan LA; Trout AT; Lam S; Singh R; Tkach JA; Serai SD; Miethke AG; Dillman JR
Abdom Radiol (NY); 2020 Jan; 45(1):168-176. PubMed ID: 31422438
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography.
Tafur M; Cheung A; Menezes RJ; Feld J; Janssen H; Hirschfield GM; Jhaveri KS
Eur Radiol; 2020 Jul; 30(7):3735-3747. PubMed ID: 32130494
[TBL] [Abstract][Full Text] [Related]
7. Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study.
Trivedi PJ; Arndtz K; Abbas N; Telford A; Young L; Banerjee R; Eddowes P; Jhaveri KS; Hirschfield GM
Aliment Pharmacol Ther; 2024 Jun; 59(11):1366-1375. PubMed ID: 38571284
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores.
Ismail MF; Hirschfield GM; Hansen B; Tafur M; Elbanna KY; Goldfinger MH; Ridgway GR; Jhaveri KS
Eur Radiol; 2022 Jan; 32(1):67-77. PubMed ID: 34231037
[TBL] [Abstract][Full Text] [Related]
9. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
[No Abstract] [Full Text] [Related]
10. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
11. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.
Cristoferi L; Porta M; Bernasconi DP; Leonardi F; Gerussi A; Mulinacci G; Palermo A; Gallo C; Scaravaglio M; Stucchi E; Maino C; Ippolito D; D'Amato D; Ferreira C; Nardi A; Banerjee R; Valsecchi MG; Antolini L; Corso R; Sironi S; Fagiuoli S; Invernizzi P; Carbone M
Dig Liver Dis; 2023 Mar; 55(3):373-380. PubMed ID: 36357293
[TBL] [Abstract][Full Text] [Related]
12. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
13. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.
Selvaraj EA; Ba-Ssalamah A; Poetter-Lang S; Ridgway GR; Brady JM; Collier J; Culver EL; Bailey A; Pavlides M
Hepatol Commun; 2022 Apr; 6(4):795-808. PubMed ID: 34802195
[TBL] [Abstract][Full Text] [Related]
14. The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.
Segal D; Marotta P; Mosli M; Zou G; Feagan BG; Al-Judaibi B
Saudi J Gastroenterol; 2019; 25(3):152-158. PubMed ID: 31044745
[TBL] [Abstract][Full Text] [Related]
15. The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
Cazzagon N; Lemoinne S; El Mouhadi S; Trivedi PJ; Gaouar F; Kemgang A; Ben Belkacem K; Floreani A; Hirschfield G; Chretien Y; Housset C; Motta R; Russo FP; Chazouillères O; Arrivé L; Corpechot C
Am J Gastroenterol; 2019 Dec; 114(12):1878-1885. PubMed ID: 31738286
[TBL] [Abstract][Full Text] [Related]
16. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Zenouzi R; Liwinski T; Yamamura J; Weiler-Normann C; Sebode M; Keller S; Lohse AW; Schramm C;
Aliment Pharmacol Ther; 2018 Jul; 48(2):169-178. PubMed ID: 29741240
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography.
Textor HJ; Flacke S; Pauleit D; Keller E; Neubrand M; Terjung B; Gieseke J; Scheurlen C; Sauerbruch T; Schild HH
Endoscopy; 2002 Dec; 34(12):984-90. PubMed ID: 12471543
[TBL] [Abstract][Full Text] [Related]
18. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.
Lemoinne S; Cazzagon N; El Mouhadi S; Trivedi PJ; Dohan A; Kemgang A; Ben Belkacem K; Housset C; Chretien Y; Corpechot C; Hirschfield G; Floreani A; Motta R; Gallix B; Barkun A; Barkun J; Chazouillères O; Arrivé L
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2785-2792.e3. PubMed ID: 30880273
[TBL] [Abstract][Full Text] [Related]
19. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
20. Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture.
Poetter-Lang S; Ba-Ssalamah A; Messner A; Bastati N; Ambros R; Kristic A; Kittinger J; Pochepnia S; Ba-Ssalamah SA; Hodge JC; Halilbasic E; Venkatesh SK; Kartalis N; Ringe K; Arrivé L; Trauner M
Eur Radiol; 2024 Jun; ():. PubMed ID: 38869640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
